Solution reagent kit AVENIO

for researchNGSliquid

The AVENIO ctDNA Surveillance Kit is a next-generation sequencing (NGS) liquid biopsy research assay that’s specially designed and optimized for longitudinal tumor burden monitoring in lung cancer and colorectal cancer (CRC) research. The Surveillance panel contains 197 genes, including those in U.S. National Comprehensive Cancer Network (NCCN) Guidelines. Features and Benefits Includes genes in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines1 All four mutation classes (SNVs, indels, fusions and CNVs) in a single assay Exceptional analytical performance supported by integrated digital error suppression (iDES) strategies combining molecular barcodes with in silico error suppression techniques2,3 Includes reagents, bioinformatics and software Streamlined, end-to-end research workflow from extraction to analysis and reporting in five days